Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials

Leow J. J., Martin-Doyle W., Rajagopal P. S., Patel C. G., Anderson E. M., Rothman A. T., ...Daha Fazla

EUROPEAN UROLOGY, cilt.66, sa.1, ss.42-54, 2014 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 66 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1016/j.eururo.2013.08.033
  • Dergi Adı: EUROPEAN UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.42-54
  • Anahtar Kelimeler: Muscle-invasive bladder cancer, Adjuvant chemotherapy, Perioperative chemotherapy, Meta-analysis, RADICAL CYSTECTOMY, PHASE-III, PERIOPERATIVE CHEMOTHERAPY, UROTHELIAL CANCER, CISPLATIN, NEOADJUVANT, CARCINOMA, THERAPY, MODEL, RISK
  • Ankara Üniversitesi Adresli: Hayır

Özet

Context: The role of adjuvant chemotherapy remains poorly defined for the management of muscle-invasive bladder cancer (MIBC). The last meta-analysis evaluating adjuvant chemotherapy, conducted in 2005, had limited power to fully support its use.